Deakin University
Browse
pruis-costeffectivenessanalysis-2019.pdf (256.03 kB)

Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore

Download (256.03 kB)
journal contribution
posted on 2019-01-01, 00:00 authored by Sil-ling PruisSil-ling Pruis, Mohamed Ismail Abdul Aziz, Fiona Pearce, Min Han Tan, David Bin-Chia Wu, Kwong Ng
Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore

History

Journal

International Journal of Technology Assessment in Health Care

Volume

35

Issue

2

Pagination

126 - 133

Publisher

Cambridge University Press

Location

Cambridge, Eng.

Publisher DOI

Link to full text

ISSN

0266-4623

eISSN

1471-6348

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

    Research Publications

    Categories

    No categories selected

    Keywords

    Cost-effectiveness analysisRenal cell carcinomaSunitinibTKITyrosine kinase inhibitor

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC